ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

GENE Genetic Technologies Ltd

1.72
-0.05 (-2.82%)
08 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Genetic Technologies Ltd GENE NASDAQ Depository Receipt
  Price Change Price Change % Share Price Last Trade
-0.05 -2.82% 1.72 10:00:00
Open Price Low Price High Price Close Price Previous Close
1.75 1.69 1.8426 1.69 1.77
more quote information »

Recent News

Date Time Source Heading
05/6/202422:00GLOBEGeneType and Stayhealthy Announce Landmark Distribution..
05/6/202420:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/5/202422:00GLOBEGTG Launches Revolutionary geneType Test covering 100% Risk..
29/5/202420:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/5/202414:15EDGAR2Form EFFECT - Notice of Effectiveness
23/5/202422:00GLOBEGeneType and Humanise Health host “Know Your Risk” Event
06/5/202422:00GLOBEGTG and ‘Wellworks for You’ sign B2B sales & marketing deal..
23/4/202405:00GLOBEGenetic Technologies Announces Closing of US$2 Million..
19/4/202402:17GLOBEGenetic Technologies Announces $2 Million Registered Direct..
17/4/202422:00GLOBENew Precision Oncology Tests to Drive Personalised Therapies..
16/4/202422:00GLOBEGeneType Clinicians’ Adoption Growing - Sales up 5-Fold Year..
11/4/202422:00GLOBEGTG to pilot GeneType in Breast Screen centers across the..
08/4/202422:00GLOBEEVENT - Empowering Women Through Knowledge; Humanise Health..
02/4/202423:05GLOBEGenetic Technologies’ Digital Strategy Ignites Significant..
26/3/202423:00GLOBEGTG Global Collaborations and Innovation Update
25/3/202423:00GLOBEGENE to develop Worlds Most Advanced Comprehensive Risk Test..
27/2/202400:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/2/202400:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/2/202406:14EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
01/2/202400:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01/2/202400:00GLOBELaunching our most comprehensive test and expanding into new..
10/1/202400:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/1/202400:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/1/202400:00GLOBEGenetic Technologies Regains Compliance with Nasdaq Minimum..
29/12/202300:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/12/202300:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21/12/202309:00EDGAR2Form F-3 - Registration statement by foreign private issuers
15/12/202300:00GLOBEGeneType's Groundbreaking Saliva Test Transforms Early..
13/12/202300:00GLOBEGenetic Technologies Limited Announces Ordinary Share..
30/10/202323:00GLOBEGene Business Update: Private Hospital Partnership; Expanded..
18/10/202323:30GLOBEGeneType Predicting Risk of Pancreatic Cancer: Major..
27/9/202323:00GLOBEGTG Signs Precision Medicine Pilot with Australia’s Largest..
12/9/202322:00GLOBEBreakthrough: GeneType for Pancreatic Cancer, Melanoma, and..
11/9/202322:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/9/202322:30GLOBEGENE Positioned at the Forefront of Multi-cancer Clinical..
11/9/202322:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
02/9/202300:00GLOBEGenetic Technologies Limited and 60 Degrees Pharmaceuticals..
30/8/202322:45GLOBEAnnual Results – Momentum Building on our Commercial Plans
09/8/202322:00GLOBEGenetic Technologies Limited Announces Updated Investor..
28/7/202322:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/7/202322:00GLOBEQuarterly Activities Update: Encouraging Growth for geneType..
21/7/202322:00GLOBEGenetic Technologies Receives Nasdaq Notification Regarding..